Clinical Trial Update: dCell Vascular Patch in Peripheral Vascular Surgery Study for CE Mark Submission [NA]

View source ↗

Summary

The completed study of the dCell Vascular Patch in peripheral arterial occlusion is being used to support CE Mark submission by Tissue Regenix Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• dCell Vascular Patch

Snippet

Sponsor: Tissue Regenix Ltd | Conditions: Peripheral Arterial Vascular Occlusion | NA | Status: COMPLETED